| 000 | 01038 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512212727.0 | ||
| 264 | 0 | _c19830421 | |
| 008 | 198304s 0 0 hun d | ||
| 022 | _a0030-6002 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKelemen, E | |
| 245 | 0 | 0 |
_a[Short-term massive myelobromol therapy in polycythemia vera: a 12-years' experience. Model for a clinical trial of cytostatic drugs]. _h[electronic resource] |
| 260 |
_bOrvosi hetilap _cJan 1983 |
||
| 300 |
_a3-13 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAlkylating Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMannitol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMitobronitol _xadverse effects |
| 650 | 0 | 4 |
_aPancytopenia _xchemically induced |
| 650 | 0 | 4 |
_aPolycythemia Vera _xdrug therapy |
| 773 | 0 |
_tOrvosi hetilap _gvol. 124 _gno. 1 _gp. 3-13 |
|
| 999 |
_c6402643 _d6402643 |
||